BOSTON, June 17, 2025--(BUSINESS WIRE)--Abcore®, a brand operating within the Antibody Solutions (AbS) business division as a part of Fortis Life Sciences®, an innovation leader in VHH discovery and ...
The p210 product is the hallmark of chronic myeloid leukemia (CML), 5 while p230 seems to be predominantly associated with chronic neutrophilic leukemia. 6 Studies on childhood and adult acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback